G31.85 Corticobasal degeneration

Name of the Condition

• Corticobasal degeneration

Summary

Corticobasal degeneration is a rare neurodegenerative disorder characterized by progressive deterioration of the cerebral cortex and basal ganglia. It leads to a combination of motor, cognitive, and behavioral symptoms, with asymmetric onset and progression. The condition is part of a group of tauopathies, involving abnormal accumulation of the tau protein in the brain.

Causes

The exact cause of corticobasal degeneration is not fully understood, but it is associated with abnormal tau protein aggregation in neurons and glial cells. Genetic factors may play a role, as some cases have been linked to mutations in the MAPT gene, which encodes tau. Environmental or sporadic factors are also considered, though no single definitive cause has been identified.

Risk Factors

• Age: Typically affects individuals over 60 years old.
• Genetic predisposition: Family history of neurodegenerative disorders may increase risk.
• Sex: Slightly more common in women than men.

Symptoms

• Asymmetric limb rigidity or dystonia
• Apraxia (difficulty with purposeful movements)
• Cognitive decline, including executive dysfunction
• Language disturbances (e.g., aphasia)
• Myoclonus (sudden muscle jerks)
• Sensory deficits or neglect of one side of the body

Diagnosis

Diagnosis is based on clinical evaluation, including neurological exams to assess motor and cognitive function. Imaging studies such as MRI may show characteristic brain atrophy, particularly in the frontal and parietal lobes. Positron emission tomography (PET) or single-photon emission computed tomography (SPECT) can help identify metabolic changes. Definitive diagnosis often requires postmortem examination to confirm tau pathology.

Treatment Options

Treatment focuses on managing symptoms, as no cure exists. Medications may include levodopa for motor symptoms, though response is often limited. Physical and occupational therapy can help maintain mobility and function. Speech therapy may address language or swallowing difficulties. Supportive care, including assistive devices, is important for quality of life.

Prognosis and Follow-Up

Corticobasal degeneration is progressive, with symptoms worsening over time. The average survival after onset is 6 to 8 years, though variability exists. Regular follow-up with a neurologist is essential to monitor disease progression and adjust symptomatic treatments. Palliative care may be considered in advanced stages.

Complications

• Severe motor impairment leading to loss of independence
• Dysphagia (difficulty swallowing), increasing aspiration risk
• Cognitive decline progressing to dementia
• Mood changes or behavioral disturbances
• Falls due to balance and gait issues

Lifestyle & Prevention

No specific prevention strategies are known, as the cause is not fully understood. Maintaining overall brain health through regular exercise, a balanced diet, and cognitive stimulation may support general well-being. Avoiding head injuries and managing vascular risk factors (e.g., hypertension) is advisable.

When to Seek Professional Help

Seek medical attention if you or a loved one experiences progressive, asymmetric motor or cognitive symptoms, such as unexplained limb stiffness, difficulty with coordination, or changes in behavior. Early evaluation by a neurologist can help rule out other conditions and guide management.

Tips for Medical Coders

When coding for corticobasal degeneration, use ICD-10-CM code G31.85. Ensure documentation supports the diagnosis, including clinical findings, imaging results, and any relevant family history. Note that this code is specific to corticobasal degeneration and should not be used for other neurodegenerative conditions. Verify that the code aligns with the patient's documented symptoms and diagnostic workup.